Track Orthofix Medical's long-term debt ($230M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), OFIX shows a long-term debt of $230M. That compares with $190M in the prior-year period — up 24.8% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, OFIX's long-term debt is now $230M (was $190M) — a 24.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Orthofix Medical is outperforming or lagging.
Tracking OFIX's long-term debt over time shows whether Orthofix Medical is scaling, shrinking, or reshaping that part of the business. The current reading is $230M That compares with $190M in the prior-year period — up 24.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this long-term debt page, Stockcircle has Orthofix Medical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $230M) with ownership activity and broader fundamentals.
Orthofix Medical's long-term debt is $230M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.